Market closed

Capricor/CAPR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Capricor

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Ticker

CAPR
Trading on

Industry

Biotechnology

Employees

102

Capricor Metrics

BasicAdvanced
$765M
Market cap
-
P/E ratio
-$0.93
EPS
4.02
Beta
-
Dividend rate
$765M
4.02
$17.51
$2.68
4.5M
1.372
1.334
9.077
15.969
-44.49%
-392.69%
23.866
60.2
60.2
-17.975
187.15%
-19.99%
339.61%
3.47%

What the Analysts think about Capricor

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Capricor stock.

Capricor Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Capricor Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy CAPR

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Capricor stock?

Capricor (CAPR) has a market cap of $765M as of October 06, 2024.

What is the P/E ratio for Capricor stock?

The price to earnings (P/E) ratio for Capricor (CAPR) stock is 0 as of October 06, 2024.

Does Capricor stock pay dividends?

No, Capricor (CAPR) stock does not pay dividends to its shareholders as of October 06, 2024.

When is the next Capricor dividend payment date?

Capricor (CAPR) stock does not pay dividends to its shareholders.

What is the beta indicator for Capricor?

Capricor (CAPR) has a beta rating of 4.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.